Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G K Feld

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Circulation|November 9, 2000
Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) studyS Singh, R G Zoble, L Yellen, et al.
Circulation|November 11, 1999
Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillationM M Rahme, B Cotter, E Leistad, et al.
The American Journal of Cardiology|September 15, 1991
Successful radiofrequency catheter ablation of accessory pathways that recurred after surgeryP S Chen, G K Feld, W P Dembitsky, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 1, 1999
Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythmU Birgersdotter-Green, K Undesser, O Fujimura, et al.
Circulation|October 1, 1992
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniquesG K Feld, R P Fleck, P S Chen, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutterM M Rahme, G A Ungab, M Wadhwa, et al.
Pacing and Clinical Electrophysiology : PACE|July 1, 1991
Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmiasG K Feld, R M Luceri, A J Greenspon, et al.
Circulation|January 1, 1991
Epicardial activation and repolarization patterns in patients with right ventricular hypertrophyP S Chen, K M Moser, W P Dembitsky, et al.
Circulation|July 1, 1993
Relation between upper limit of vulnerability and defibrillation threshold in humansP S Chen, G K Feld, J M Kriett, et al.
Cell|September 28, 2000
A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineagesV T Nguyên-Trân, S W Kubalak, S Minamisawa, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Circulation|November 9, 2000
Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) studyS Singh, R G Zoble, L Yellen, et al.
Circulation|November 11, 1999
Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillationM M Rahme, B Cotter, E Leistad, et al.
The American Journal of Cardiology|September 15, 1991
Successful radiofrequency catheter ablation of accessory pathways that recurred after surgeryP S Chen, G K Feld, W P Dembitsky, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 1, 1999
Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythmU Birgersdotter-Green, K Undesser, O Fujimura, et al.
Circulation|October 1, 1992
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniquesG K Feld, R P Fleck, P S Chen, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutterM M Rahme, G A Ungab, M Wadhwa, et al.
Pacing and Clinical Electrophysiology : PACE|July 1, 1991
Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmiasG K Feld, R M Luceri, A J Greenspon, et al.
Circulation|January 1, 1991
Epicardial activation and repolarization patterns in patients with right ventricular hypertrophyP S Chen, K M Moser, W P Dembitsky, et al.
Circulation|July 1, 1993
Relation between upper limit of vulnerability and defibrillation threshold in humansP S Chen, G K Feld, J M Kriett, et al.
Cell|September 28, 2000
A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineagesV T Nguyên-Trân, S W Kubalak, S Minamisawa, et al.
Pageof 5